Stifel analyst Andreas Heine downgraded EMS-Chemie to Hold from Buy with a price target of CHF 700, down from CHF 810. The analyst expects a weak Q4 amid destocking and sees a lack of catalysts for the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly